JP2018537113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537113A5 JP2018537113A5 JP2018531335A JP2018531335A JP2018537113A5 JP 2018537113 A5 JP2018537113 A5 JP 2018537113A5 JP 2018531335 A JP2018531335 A JP 2018531335A JP 2018531335 A JP2018531335 A JP 2018531335A JP 2018537113 A5 JP2018537113 A5 JP 2018537113A5
- Authority
- JP
- Japan
- Prior art keywords
- cell culture
- culture medium
- dry powder
- pellet
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008188 pellet Substances 0.000 claims description 66
- 239000006143 cell culture medium Substances 0.000 claims description 49
- 239000000843 powder Substances 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 30
- 239000002609 medium Substances 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 24
- 239000011230 binding agent Substances 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 19
- 238000012258 culturing Methods 0.000 claims description 15
- 235000015097 nutrients Nutrition 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 239000000654 additive Substances 0.000 claims description 11
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 230000000996 additive effect Effects 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 235000000346 sugar Nutrition 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 239000005445 natural material Substances 0.000 claims description 4
- 238000009987 spinning Methods 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 150000002016 disaccharides Chemical class 0.000 claims description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000001125 extrusion Methods 0.000 claims description 2
- 229920002994 synthetic fiber Polymers 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims 3
- 239000007640 basal medium Substances 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000007383 open-end spinning Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 24
- 229940024606 amino acid Drugs 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000000337 buffer salt Substances 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- -1 feed Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000012577 media supplement Substances 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021072968A JP7357657B2 (ja) | 2015-12-17 | 2021-04-23 | 細胞培養に使用されるペレットおよびその製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562269031P | 2015-12-17 | 2015-12-17 | |
| US62/269,031 | 2015-12-17 | ||
| PCT/US2016/067374 WO2017106783A1 (en) | 2015-12-17 | 2016-12-16 | Pellets used in cell culture and methods of making thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021072968A Division JP7357657B2 (ja) | 2015-12-17 | 2021-04-23 | 細胞培養に使用されるペレットおよびその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018537113A JP2018537113A (ja) | 2018-12-20 |
| JP2018537113A5 true JP2018537113A5 (cg-RX-API-DMAC7.html) | 2019-12-19 |
| JP6876049B2 JP6876049B2 (ja) | 2021-05-26 |
Family
ID=57738000
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531335A Active JP6876049B2 (ja) | 2015-12-17 | 2016-12-16 | 細胞培養に使用されるペレットおよびその製造方法 |
| JP2021072968A Active JP7357657B2 (ja) | 2015-12-17 | 2021-04-23 | 細胞培養に使用されるペレットおよびその製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021072968A Active JP7357657B2 (ja) | 2015-12-17 | 2021-04-23 | 細胞培養に使用されるペレットおよびその製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10822584B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3271452B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6876049B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180091923A (cg-RX-API-DMAC7.html) |
| CN (1) | CN108495926A (cg-RX-API-DMAC7.html) |
| RU (2) | RU2759945C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201805049TA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017106783A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020218584A1 (ja) * | 2019-04-26 | 2020-10-29 | 味の素株式会社 | 細胞培養用組成物 |
| US20220372435A1 (en) * | 2019-09-19 | 2022-11-24 | Life Technologies Corporation | Cell Culture Media Tablets and Methods of Manufacture |
| CN116438295A (zh) | 2020-06-22 | 2023-07-14 | 生命技术公司 | 培养多能细胞悬浮液的方法和组合物 |
| US20230287334A1 (en) * | 2020-07-14 | 2023-09-14 | Corning Incorporated | Rapidly dissolving cell culture media powder and methods of making the same |
| JP2023544507A (ja) * | 2020-09-22 | 2023-10-24 | アルフィニティ ユーエスエイ，インコーポレイテッド | バイオプロセスおよび医薬用途の流体を調製するためのシステムおよび方法 |
| JP7651417B2 (ja) | 2021-09-09 | 2025-03-26 | 株式会社クボタ | 自動走行制御システムおよび圃場作業車 |
| KR102633825B1 (ko) * | 2021-10-18 | 2024-02-02 | 연세대학교 산학협력단 | 박테리아를 이용한 가스 중 질소산화물의 저감 방법 및 시스템 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2379001A (en) | 1944-05-20 | 1945-06-26 | Leonard W Moen | Device for removing and applying chain links |
| SU1275042A1 (ru) * | 1984-12-28 | 1986-12-07 | Научно-Исследовательский Институт По Производству Питательных Сред, Г.Махачкала | Способ производства сухих питательных сред |
| DE3609133A1 (de) | 1986-03-19 | 1987-09-24 | Glatt Gmbh | Vorrichtung zum pelletieren od. dgl. behandeln von teilchen sowie damit durchfuehrbares verfahren |
| US4962091A (en) * | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
| JPH0257175A (ja) | 1988-08-19 | 1990-02-26 | Morinaga & Co Ltd | 成形培地及びその製造法 |
| US5132142A (en) * | 1991-03-19 | 1992-07-21 | Glatt Gmbh | Apparatus and method for producing pellets by layering power onto particles |
| JP3347366B2 (ja) * | 1992-06-23 | 2002-11-20 | 塩野義製薬株式会社 | 転動造粒装置及び方法 |
| CA2261292C (en) * | 1996-07-25 | 2008-09-30 | Genzyme Corporation | Chondrocyte media formulations and culture procedures |
| AU4330597A (en) * | 1996-08-30 | 1998-03-19 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
| US6383810B2 (en) * | 1997-02-14 | 2002-05-07 | Invitrogen Corporation | Dry powder cells and cell culture reagents and methods of production thereof |
| US20060286668A1 (en) * | 1999-04-30 | 2006-12-21 | Invitrogen Corporation | Animal-cell culture media comprising non-animal or plant-derived nutrients |
| JP2001170473A (ja) * | 1999-12-17 | 2001-06-26 | Hosokawa Micron Corp | 造粒装置 |
| AU2002232406C1 (en) * | 2000-11-06 | 2009-03-05 | Invitrogen Corporation | Dry powder cells and cell culture reagents and methods of production thereof |
| CN1657604A (zh) * | 2005-02-07 | 2005-08-24 | 黄宗堂 | 一种培养基的配制和使用方法 |
| FR2910024B1 (fr) * | 2006-12-19 | 2009-03-27 | Agronomique Inst Nat Rech | Milieu de culture synthetique chimiquement defini. |
| EP2563904B1 (en) * | 2010-04-26 | 2015-01-21 | Novartis AG | Improved cell culture medium |
| CN103261404B (zh) * | 2010-12-16 | 2017-06-09 | 默克专利有限公司 | 干的颗粒状细胞培养基 |
| KR102007997B1 (ko) | 2011-02-07 | 2019-08-07 | 라이프 테크놀로지스 코포레이션 | 감수성 화합물을 안정화시키는 조성물 및 방법 |
| EP2794853B1 (en) * | 2011-12-22 | 2020-04-22 | Life Technologies Corporation | Cell culture media and methods |
| EP2882842B1 (en) * | 2012-08-07 | 2019-02-20 | 3M Innovative Properties Company | Method of making agglomerated microbiological media and compositions thereof |
| CN104096510A (zh) * | 2013-04-12 | 2014-10-15 | 上海源培生物科技有限公司 | 利用流化床干燥技术混匀培养基成分的工艺 |
| US20150275167A1 (en) * | 2014-03-28 | 2015-10-01 | Corning Incorporated | Composition and method for cell culture sustained release |
-
2016
- 2016-12-16 SG SG11201805049TA patent/SG11201805049TA/en unknown
- 2016-12-16 WO PCT/US2016/067374 patent/WO2017106783A1/en not_active Ceased
- 2016-12-16 CN CN201680079612.1A patent/CN108495926A/zh active Pending
- 2016-12-16 KR KR1020187020525A patent/KR20180091923A/ko active Pending
- 2016-12-16 US US15/566,899 patent/US10822584B2/en active Active
- 2016-12-16 EP EP16822591.0A patent/EP3271452B1/en active Active
- 2016-12-16 EP EP21212458.0A patent/EP4036220A1/en not_active Withdrawn
- 2016-12-16 RU RU2018124447A patent/RU2759945C2/ru active
- 2016-12-16 RU RU2021132093A patent/RU2021132093A/ru unknown
- 2016-12-16 JP JP2018531335A patent/JP6876049B2/ja active Active
-
2020
- 2020-09-29 US US17/037,454 patent/US20210009942A1/en active Pending
-
2021
- 2021-04-23 JP JP2021072968A patent/JP7357657B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018537113A5 (cg-RX-API-DMAC7.html) | ||
| RU2018124447A (ru) | Гранулы, используемые в клеточной культуре, и способы их получения | |
| KR101052573B1 (ko) | 균일한 함량을 갖는 과립형 동물 사료 첨가제를 제조하는 방법 및 그에 의하여 제조되는 과립형 동물 사료 첨가제 | |
| CN104087639B (zh) | 一种从葵花盘中提取小分子活性物质的方法 | |
| CN104757273B (zh) | 一种制备颗粒型苏氨酸产品的工艺 | |
| CZ297917B6 (cs) | Zpusob výroby suchých amorfních produktu, amorfnímikroskopicky homogenní produkty a jejich pouzitía pouzití smesi látek ke stabilizaci biologicky aktivního materiálu | |
| US11028361B2 (en) | Compositions and methods for stabilizing susceptible compounds | |
| RU2018144108A (ru) | Никотиносодержащие частицы | |
| CN104150970B (zh) | 一种颗粒磷酸铵镁缓释肥的圆盘造粒方法 | |
| CN103262840B (zh) | 一种6-苄氨基嘌呤可溶粒剂及其配制方法 | |
| CN104726335A (zh) | 一种利用赖氨酸废母液生产颗粒蛋白的方法 | |
| KR102657720B1 (ko) | 높은 감마-아미노부티르산 함량을 갖는 로즈베이 윌로우허브 음료를 생산하는 방법 | |
| ES2385046T3 (es) | Procedimiento de secado por pulverización para producir un polvo o granulado de carnitina seco | |
| CN105669283A (zh) | 一种茶树叶面肥 | |
| DE102017203908B3 (de) | Kulturmedium, umfassend Oligopeptide | |
| KR102426186B1 (ko) | 버섯 추출분말 제조 방법 | |
| CN101374529B (zh) | 使s-腺苷-l-甲硫氨酸稳定化的方法以及稳定化后的组合物 | |
| CN115590118B (zh) | 一种类黑精组合物及其制备方法 | |
| RU2369618C1 (ru) | Комплексная соль олигохитозония и способ получения этой соли | |
| KR101617858B1 (ko) | 습식 과립화된 세포 배양 배지 및 그 제조방법 | |
| CA3009952A1 (en) | Layered cell culture particles and methods of making thereof | |
| JPS6023391A (ja) | エノキダケ抽出物 | |
| KR102908392B1 (ko) | 낮은 점도를 갖는 미세조류 농축액을 제조하는 방법 | |
| CN109481405B (zh) | 复方氨基酸颗粒（9aa）及其制备方法 | |
| RU2299062C1 (ru) | Способ распылительного высушивания биологически активного препарата |